Webinar
Integrating Immunotherapy into Early-Stage Lung Cancer
Date:
Fri 29 Dec, 2023 8:00–9:00pm
Duration:
1 hour
What the session is about
Discussion (8:00 to 8:45 pm)
- Treatment for stages 1 to 3A
- Induction chemotherapy
- Surgery with adjuvant chemotherapy or radiotherapy
- Immune checkpoint inhibitors in early-stage NSCLC
- Usage of inhibitors in early NSCLC
Interactive Q&A (8:45 to 9:00 pm)
- Register now and send your questions through the chat window
- You can also send questions 'Live' during the Webinar on December 29th through the chat window below the video
About the presenter:
Dr. Shyam Aggarwal (Chairman and head of the Department of Medical Oncology at Sir Ganga Ram Hospital, New Delhi)
- He completed his MBBS and M.D. in Internal Medicine, achieving a Silver Medal.
- He has been awarded the NIH-International Fogarty Fellowship for training in the field of bone marrow, transplantation and basic medical research at UCLA. Los Angeles, USA
- He is an editor of a few Journals & one of the advisory Board members in Merck Pharmaceuticals, Roche Pharmaceuticals, J & J Pharmaceuticals, AstraZeneca Pharmaceuticals, and Intas Pharmaceuticals
- He is been a member of multiple Educational and Medical Organisations for example ASCO, EHA, ISMPO, ISO, and APOCP
- He is been a co-author of several paper publications, the recent one is the Clinical Plasma Metabolite Panel correlating with Response to Anti PD-1 Therapy in Patients with Advanced Lung Cancer in April 2023 and Submitted to frontiers in molecular biosciences
- There are around 22 international conferences & educational activities organised under the doctor's supervision
- He has been a principal investigator in numerous Clinical Trials
